Last reviewed · How we verify
NCT03752437
Comparison of Two Dosages of Heparin Before Extracorporeal Circulation
Phase 4 trial testing ACT (Activated Clotting Time) in Extracorporeal Circulation; Complications in 150 participants. Completed in 30 September 2021.
30 September 2021
Quick facts
| Lead sponsor | Astes |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 150 |
| Start date | 1 October 2019 |
| Primary completion | 30 September 2021 |
| Estimated completion | 30 September 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- ACT (Activated Clotting Time)
- Heparin (HEPARIN) — full drug profile →
Conditions studied
- Extracorporeal Circulation; Complications — all drugs for Extracorporeal Circulation; Complications →
Sponsor
Astes — full company profile →
Who can join
18 and older, any sex, with Extracorporeal Circulation; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study the investigators will study two dosages of heparin before extracorporeal circulation in open chest cardiac surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03752437
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Extracorporeal Circulation; Complications
Currently open trials in the same condition.
- NCT06754709 — Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children · recruiting
- NCT06179771 — Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support. · NA · recruiting
- NCT05669183 — Hemodynamic Comparison of Peripheral and Central VA ECMO. · recruiting
- NCT06095518 — DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study · recruiting
- NCT05487612 — MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) · NA · recruiting
Other Astes trials
Trials by the same sponsor.
- NCT05711329 — Comparison of Methodology Proposed by the SFAR for the Detection by Videoconference of Obstructive Sleep Apnea. · not yet recruiting
- NCT05709964 — Comparison of Demographic Data Mentioned by the Patients or Measured by a Physician · completed
- NCT03983564 — Derivation and Validation of a Combination of BOSTON Score and DES-OSA Score for Selection of OSA Patients. · completed
- NCT05345665 — Comparison of Three Methods of Anesthesia to Achieve a Nerve Block Anesthesia. · NA · completed
- NCT03743090 — Influence of Extracorporeal Circulation on the Development of OSA (Obstructive Sleep Apnea) · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03752437 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Astes
- Last refreshed: 15 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03752437.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing